Corrigendum to "Individual and common inhibitors of coronavirus and picornavirus main proteases" [FEBS Lett. 583 (2009) 549-555] (DOI:10.1016/j.febslet.2008.12.059);Individual and common inhibitors of coronavirus and picornavirus main proteases

FEBS Letters

Volumn 583, Issue 3, 2009, Pages 549-555

  Kuo, Chih Jung ^a,b   Liu, Hun Ge ^a   Lo, Yueh Kuei ^a   Seong, Churl Min ^c   Lee, Kee In ^c   Jung, Young Sik ^c   Liang, Po Huang ^a,b  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

3C protease; Computer modeling; Coronavirus; Fluorescence assay; High throughput screening; Picornavirus

Indexed keywords

PROTEINASE INHIBITOR;

ARTICLE; COMPUTER MODEL; CONCENTRATION RESPONSE; CORONAVIRUS; HIGH THROUGHPUT SCREENING; PICORNAVIRUS; PRIORITY JOURNAL; VIRUS INHIBITION;

CORONAVIRUS; PICORNAVIRIDAE; RNA VIRUSES; SARS CORONAVIRUS;

EID: 58649118410     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.05.008     Document Type: Erratum

References (21)

1. Melnick, J.L. (1996) Enterovirus: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In Virology, 3rd ed., Lippincott-Raven, Philadephia, PA.
2. Blomberg K., et al. New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouse disease. Lancet 2 (1974) 112
3. Sperber S.J., and Hayden F.G. Chemotherapy of rhinovirus colds. Antimicrob. Agents Chemother. 32 (1998) 409-414
4. Lum L.C., et al. Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet 352 (1998) 1391
5. Ho M., et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. New Engl. J. Med. 341 (1999) 929-935
6. Lee C.K., et al. Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate. J. Gen. Virol. 86 (2005) 197-210
7. Krausslich H.G., and Wimmer E. Viral proteinases. Annu. Rev. Biochem. 57 (1998) 701-754
8. Ksiazek T.G., et al. A novel coronavirus associated with severe acute respiratory syndrome. New Eng. J. Med. 348 (2003) 1953-1966
9. Patick A.K. Rhinovirus chemotherapy. Antiviral Res. 71 (2006) 391-396
10. Lee E.S., et al. Development of potent inhibitors of the coxsackievirus 3C protease. Biochem. Biophys. Res. Commun. 358 (2007) 7-11
11. Maugeri C., et al. New anti-viral drugs for the treatment of the common cold. Bioorg. Med. Chem. 16 (2008) 3091-3107
12. Kuo C.J., et al. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg. Med. Chem. 16 (2008) 7388-7398
13. Liang P.H. Characterization and inhibition of SARS-coronavirus main protease. Curr. Top Med. Chem. 6 (2006) 361-376
14. De Clercq E. Potential antivirals and antiviral strategies against SARS coronavirus infections. Expert Rev. Anti Infect. Ther. 4 (2006) 291-302
15. Zhai S., Liu W., and Yan B. Recent patents on treatment of severe acute respiratory syndrome (SARS). Recent Patents Anti-Infect Drug Disc. 2 (2007) 1-10
16. Binford S.L., et al. Conservation of amino acids in rhinovirus 3C protease correlates with broad-spectrum activity of rupintrivir, a novel rhinovirus 3C protease inhibitor. Antimicrob. Agents Chemother. 49 (2005) 619-626
17. Shie J.J., et al. Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic α,β-unsaturated esters. Bioorg. Med. Chem. 13 (2005) 5240-5252
18. Kuo C.J., et al. Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate. Biophys. Biochem. Res. Commun. 318 (2004) 862-867
19. Yang H., et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. USA 100 (2003) 13190-13195
20. Matthews D.A., et al. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl. Acad. Sci. USA 96 (1999) 11000-11007
21. Yang S., et al. Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor. J. Med. Chem. 49 (2007) 4971-4980